Literature DB >> 32293020

[Palliation in patients with severe COVID-19].

Magnus Ekström1, Bengt Dahlander2.   

Abstract

Coronavirus Disease 2019 (COVID-19) can cause severe respiratory failure and distressing symptoms including fever, cough, breathlessness and anxiety. Symptomatic (palliative) treatment is of fundamental importance both in conjuncture with life-sustaining interventions and in end of life care. Based on the evidence to date, there are several treatment options to consider for the relief of fever (acetaminophen, NSAID, oral glucocorticoids), cough (morphine), breathlessness (morphine, oxygen, fan), anxiety (benzodiazepines) and pain (NSAID, morphine). Top priorities include precautions to protect staff and people at-risk from infection and planning how to provide adequate treatment for each individual depending on setting, including palliative care.

Entities:  

Mesh:

Year:  2020        PMID: 32293020

Source DB:  PubMed          Journal:  Lakartidningen        ISSN: 0023-7205


  1 in total

1.  Angiotensin converting enzyme-2 as therapeutic target in COVID-19.

Authors:  Neda Roshanravan; Samad Ghaffari; Mehdi Hedayati
Journal:  Diabetes Metab Syndr       Date:  2020-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.